161 related articles for article (PubMed ID: 32317145)
1. RINGO/Speedy proteins, a family of non-canonical activators of CDK1 and CDK2.
Gonzalez L; Nebreda AR
Semin Cell Dev Biol; 2020 Nov; 107():21-27. PubMed ID: 32317145
[TBL] [Abstract][Full Text] [Related]
2. Identification and comparative analysis of multiple mammalian Speedy/Ringo proteins.
Cheng A; Xiong W; Ferrell JE; Solomon MJ
Cell Cycle; 2005 Jan; 4(1):155-65. PubMed ID: 15611625
[TBL] [Abstract][Full Text] [Related]
3. Negative regulation of cell-cycle progression by RINGO/Speedy E.
Dinarina A; Ruiz EJ; O'Loghlen A; Mouron S; Perez L; Nebreda AR
Biochem J; 2008 Mar; 410(3):535-42. PubMed ID: 18072937
[TBL] [Abstract][Full Text] [Related]
4. Biochemical characterization of Cdk2-Speedy/Ringo A2.
Cheng A; Gerry S; Kaldis P; Solomon MJ
BMC Biochem; 2005 Sep; 6():19. PubMed ID: 16191191
[TBL] [Abstract][Full Text] [Related]
5. Cell cycle regulation of the mammalian CDK activator RINGO/Speedy A.
Dinarina A; Santamaria PG; Nebreda AR
FEBS Lett; 2009 Sep; 583(17):2772-8. PubMed ID: 19622356
[TBL] [Abstract][Full Text] [Related]
6. CDK activation by non-cyclin proteins.
Nebreda AR
Curr Opin Cell Biol; 2006 Apr; 18(2):192-8. PubMed ID: 16488127
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a new family of cyclin-dependent kinase activators.
Dinarina A; Perez LH; Davila A; Schwab M; Hunt T; Nebreda AR
Biochem J; 2005 Mar; 386(Pt 2):349-55. PubMed ID: 15574121
[TBL] [Abstract][Full Text] [Related]
8. Speedy/RINGO regulation of CDKs in cell cycle, checkpoint activation and apoptosis.
Gastwirt RF; McAndrew CW; Donoghue DJ
Cell Cycle; 2007 May; 6(10):1188-93. PubMed ID: 17507798
[TBL] [Abstract][Full Text] [Related]
9. Evolution of the Cdk-activator Speedy/RINGO in vertebrates.
Chauhan S; Zheng X; Tan YY; Tay BH; Lim S; Venkatesh B; Kaldis P
Cell Mol Life Sci; 2012 Nov; 69(22):3835-50. PubMed ID: 22763696
[TBL] [Abstract][Full Text] [Related]
10. Speedy/Ringo C regulates S and G2 phase progression in human cells.
Cheng A; Solomon MJ
Cell Cycle; 2008 Oct; 7(19):3037-47. PubMed ID: 18802405
[TBL] [Abstract][Full Text] [Related]
11. The Role of Speedy/RINGO Protein in Breast Cancer as a Future Biomarker.
Tanriverdi O; Yildiz A
Cancer Diagn Progn; 2024; 4(3):209-213. PubMed ID: 38707716
[TBL] [Abstract][Full Text] [Related]
12. Differential regulation of Cdc2 and Cdk2 by RINGO and cyclins.
Karaiskou A; Perez LH; Ferby I; Ozon R; Jessus C; Nebreda AR
J Biol Chem; 2001 Sep; 276(38):36028-34. PubMed ID: 11461916
[TBL] [Abstract][Full Text] [Related]
13. Meiotic inactivation of Xenopus Myt1 by CDK/XRINGO, but not CDK/cyclin, via site-specific phosphorylation.
Ruiz EJ; Hunt T; Nebreda AR
Mol Cell; 2008 Oct; 32(2):210-20. PubMed ID: 18951089
[TBL] [Abstract][Full Text] [Related]
14. Structural basis of divergent cyclin-dependent kinase activation by Spy1/RINGO proteins.
McGrath DA; Fifield BA; Marceau AH; Tripathi S; Porter LA; Rubin SM
EMBO J; 2017 Aug; 36(15):2251-2262. PubMed ID: 28666995
[TBL] [Abstract][Full Text] [Related]
15. Speedy A-Cdk2 binding mediates initial telomere-nuclear envelope attachment during meiotic prophase I independent of Cdk2 activation.
Tu Z; Bayazit MB; Liu H; Zhang J; Busayavalasa K; Risal S; Shao J; Satyanarayana A; Coppola V; Tessarollo L; Singh M; Zheng C; Han C; Chen Z; Kaldis P; Gustafsson JÅ; Liu K
Proc Natl Acad Sci U S A; 2017 Jan; 114(3):592-597. PubMed ID: 28031483
[TBL] [Abstract][Full Text] [Related]
16. Essential role of the Cdk2 activator RingoA in meiotic telomere tethering to the nuclear envelope.
Mikolcevic P; Isoda M; Shibuya H; del Barco Barrantes I; Igea A; Suja JA; Shackleton S; Watanabe Y; Nebreda AR
Nat Commun; 2016 Mar; 7():11084. PubMed ID: 27025256
[TBL] [Abstract][Full Text] [Related]
17. Human Speedy: a novel cell cycle regulator that enhances proliferation through activation of Cdk2.
Porter LA; Dellinger RW; Tynan JA; Barnes EA; Kong M; Lenormand JL; Donoghue DJ
J Cell Biol; 2002 Apr; 157(3):357-66. PubMed ID: 11980914
[TBL] [Abstract][Full Text] [Related]
18. Cyclins and CDKS in development and cancer: lessons from genetically modified mice.
Santamaria D; Ortega S
Front Biosci; 2006 Jan; 11():1164-88. PubMed ID: 16146805
[TBL] [Abstract][Full Text] [Related]
19. Meiotic regulation of the CDK activator RINGO/Speedy by ubiquitin-proteasome-mediated processing and degradation.
Gutierrez GJ; Vögtlin A; Castro A; Ferby I; Salvagiotto G; Ronai Z; Lorca T; Nebreda AR
Nat Cell Biol; 2006 Oct; 8(10):1084-94. PubMed ID: 16964245
[TBL] [Abstract][Full Text] [Related]
20. Differential phosphorylation of T-47D human breast cancer cell substrates by D1-, D3-, E-, and A-type cyclin-CDK complexes.
Sarcevic B; Lilischkis R; Sutherland RL
J Biol Chem; 1997 Dec; 272(52):33327-37. PubMed ID: 9407125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
